May 24, 2024: Dr. Krishna Ella, Co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious…
May 18, 2024: Covaxin, an inactivated virus vaccine developed by Bharat Biotech in India, has played a significant…
May 16, 2024: A recent study in SpringerLink examining Covaxin's long-term effects offers debatable findings. While the research…
May 2, 2024: In the interest of public health, Bharat Biotech reaffirmed the safety of India's COVAXIN®️, developed…
Bharat Biotech, the Hyderabad-based vaccine maker of COVAXIN, announced that it will wait and assess the demand before…
Bharat Biotech today strongly condemned fallacious and misleading information report recently by a foreign media. The company in…
Japan on Friday accorded approval for Bharat Biotech's Covaxin booster dose for travellers. In April this year, the…
A COVAXIN booster dose has protective efficacy against the Delta variant and the Omicron sub-variants BA.1.1 and BA.2,…
Covaxin Commercialisation rights has been secured by Ocugen Inc. Ocugen and Bharat Biotech has entered into amended agreement…
COVAXIN Jabbed who were worried to know if Japan will allow entry can now relax as Japan has…
Science pays, if you are passionate, and committed towards it, COVAXIN Scientist Krishna Ella said. Addressing young entrepreneurs…
COVAXIN maker Bharat Biotech announced today that U.S. Food and Drug Administration (FDA) has lifted its clinical hold…
Sign in to your account